Investing.com - Clovis reported on Friday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Clovis announced earnings per share of $-0.390 on revenue of $30.66M. Analysts polled by Investing.com anticipated EPS of $-0.395 on revenue of $38.05M.
Clovis shares are down 90% from the beginning of the year and are trading at $0.266 , down-from-52-week-high.
Clovis shares lost 2.10% in intra-day trade following the report.
Clovis follows other major Healthcare sector earnings this month
Clovis's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar